trial

Cost-utility Study of a Group of Compensatory Cognitive Remediation in Schizophrenia

NCTId NCT02879604
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 218 (actual)
Sponsored by University Hospital, Montpellier
Primary completion 2023-03-28
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
218 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2018-03-05
Primary completion
2023-03-28
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Compensatory Cognitive TrainingUsual

Sponsors

University Hospital, MontpellierLead Sponsor
Assistance Publique Hopitaux De MarseilleCollaborator
University Hospital, Clermont-FerrandCollaborator
Assistance Publique - Hôpitaux de ParisCollaborator
Hôpital Louis MourierCollaborator
Centre Hospitalier Charles Perrens, BordeauxCollaborator
University Hospital, Strasbourg, FranceCollaborator
Hospital Center Alpes-IsèreCollaborator
Hôpitaux à BronCollaborator
Fondation FondaMentalCollaborator

Investigators

1
Delphine DC CAPDEVIELLE, MD-PhDStudy Director

Sites

9 total
Bordeaux, FranceBron, FranceClermont-Ferrand, FranceColombes, FranceCréteil, FranceMarseille, FranceMontpellier, FranceSaint-Égrève, FranceStrasbourg, France

Facts & assertions

4 sourced
Enrollment
218
Phase
NA
Primary Completion Date
2023-03-28
Status
COMPLETED
relationships
The graph out of here
drug
Compensatory Cognitive Training
drug
Usual
drug
lead_sponsor
University Hospital, Montpellier
company
collaborator
Assistance Publique Hopitaux De Marseille
company
University Hospital, Clermont-Ferrand
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Delphine DC CAPDEVIELLE, MD-PhD
person